Hib vaccine - Sanofi/BioPort
Alternative Names: Haemophilus influenzae vaccine - Sanofi/BioPort; Hin 47; Otitis media vaccine - Sanofi/BioPortLatest Information Update: 04 Apr 2022
At a glance
- Originator Emergent BioDefense Operations Lansing
- Class Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Otitis media
Most Recent Events
- 30 Apr 2007 Discontinued - Phase-II for Otitis media in USA (unspecified route)
- 18 Jan 2005 Aventis Pasteur is now called sanofi pasteur
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis